Chemours Company (the) · LS:A14RPH

Chemours Company (the) financial statements

Chemours Company (the)'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue5.81B5.78B6.08B6.83B6.34B4.97B5.53B6.64B6.18B5.40B
Cost of revenue4.91B4.64B4.78B5.21B4.96B3.90B4.46B4.67B4.44B4.30B
Gross profit902.0M1.14B1.30B1.62B1.38B1.07B1.06B1.97B1.75B1.10B
Research and development108.0M109.0M108.0M118.0M107.0M93.0M80.0M82.0M81.0M81.0M
Selling, general and administrative799.0M598.0M1.29B710.0M592.0M527.0M548.0M657.0M626.0M946.0M
Depreciation and amortization340.0M292.0M309.0M291.0M317.0M320.0M311.0M284.0M273.0M284.0M
Interest expense269.0M263.0M208.0M163.0M185.0M210.0M208.0M195.0M214.0M219.0M
Income before tax-277.0M106.0M-318.0M741.0M676.0M179.0M-124.0M1.16B912.0M-11.0M
Income tax109.0M37.0M-66.0M163.0M68.0M-40.0M-72.0M159.0M165.0M-18.0M
Net income-386.0M69.0M-253.0M578.0M608.0M219.0M-52.0M995.0M746.0M7.00M
Earnings per share, basic-2.570.46-1.703.723.691.33-0.325.624.040.04
Earnings per share, diluted-2.570.46-1.703.653.601.32-0.325.453.910.04

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents670.0M713.0M1.20B1.10B1.45B1.10B943.0M1.20B1.56B902.0M
Receivables562.0M619.0M509.0M509.0M644.0M449.0M602.0M790.0M847.0M742.0M
Inventory1.57B1.46B1.35B1.40B1.10B939.0M1.08B1.15B935.0M767.0M
Current assets3.00B3.02B3.84B3.21B3.35B2.63B2.78B3.29B3.49B2.55B
Property, plant and equipment3.08B3.19B3.21B3.17B3.15B3.47B3.56B3.29B3.01B2.78B
Goodwill46.0M46.0M102.0M102.0M102.0M153.0M153.0M153.0M153.0M
Total assets7.38B7.51B8.24B7.64B7.55B7.08B7.26B7.36B7.29B6.06B
Accounts payable954.0M1.16B1.16B1.23B1.16B844.0M923.0M1.14B1.07B884.0M
Current liabilities1.69B1.82B2.49B1.89B1.86B1.44B1.54B1.71B1.65B1.77B
Long-term debt4.10B4.06B3.99B3.59B3.72B4.00B4.03B3.96B4.10B3.53B
Total debt4.18B4.16B4.08B3.66B3.78B4.06B4.20B4.02B4.16B3.59B
Total liabilities7.13B6.94B7.52B6.53B6.47B6.27B6.56B6.34B6.43B5.96B
Shareholders' equity250.0M571.0M721.0M1.11B1.08B813.0M689.0M1.01B860.0M100.0M
Shares outstanding149.9M149.4M148.6M148.5M161.0M164.9M163.6M170.8M183.0M182.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations264.0M-633.0M556.0M755.0M814.0M807.0M650.0M1.14B640.0M594.0M
Capital spending-213.0M-360.0M-370.0M-307.0M-277.0M-267.0M-481.0M-498.0M-411.0M-338.0M
Free cash flow51.0M-993.0M186.0M448.0M537.0M540.0M169.0M642.0M229.0M256.0M
Cash from investing-206.0M-353.0M-229.0M-284.0M220.0M-234.0M-483.0M-487.0M-370.0M357.0M
Cash from financing-126.0M-36.0M172.0M-686.0M-554.0M-449.0M-419.0M-993.0M352.0M-396.0M
Dividends paid-78.0M-148.0M-149.0M-154.0M-164.0M-164.0M-164.0M-148.0M-22.0M-22.0M
Share buybacks-69.0M-495.0M-173.0M0-322.0M-644.0M-106.0M0
Change in cash-39.0M-1.04B503.0M-247.0M446.0M162.0M-258.0M-355.0M654.0M536.0M